Recent Finacing
Recent Raise
Adynxx is a clinical-stage pharmaceutical company developing AYX1 and related therapeutics to prevent and resolve post-surgical and chronic neuropathic/inflammatory pain, with Phase 1 and two Phase 2 studies completed.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors